AMERICAN FRIENDS OF CANCER RESEARCH INC (EIN 650520985) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1994

Legal Domicile

Principal Officer

QUINTON NEWELL

Phone

8573021100

Tax Period

2024-01-01 to 2024-12-31

AMERICAN FRIENDS OF CANCER RESEARCH INC, founded in 1994, is a community nonprofit in the Education sector that reported $7.2M in total revenue in fiscal year 2024. Revenue surged 46% from the prior year, signaling strong growth momentum. The organization ran a surplus of $3.5M, a strong 49% operating margin.

Mission

TO SUPPORT RESEARCH INTO THE CAUSES AND TREATMENT OF CANCER

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $7,210,216

Program Service Revenue $0

Investment Income $143

Other Revenue $0

TOTAL REVENUE $7,210,359

Expense Breakdown

Grants Paid $2,762,858

Salaries & Benefits $545,491

Fundraising Expenses $353,307

Program Expenses $2,965,486

Other Expenses $392,111

TOTAL EXPENSES $3,700,460

Year-over-Year Comparison

	2024	2023	Change
Revenue	$7,210,359	$4,947,229	+0.5%
Expenses	$3,700,460	$3,200,467	+0.2%
Net Income	$3,509,899	$1,746,762	+1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$175,220

Total Directors

Key Employees

$187,344

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CATHRYN DHANATYA	PRESIDENT	1.00	Officer Director	$0	$0	$0
DAN BURKWOOD	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
QUINTON NEWELL	TREASURER	1.00	Director	$0	$0	$0
GILLIAN FAIRFIELD	DIRECTOR	0.50	Director	$0	$0	$0
KATHERINE SZARAMA	DIRECTOR	1.00	Director	$0	$0	$0
SEBASTIEN LAYE	CHIEF DEVELOPMENTAL OFFICER	40.00	Officer	$159,291	$15,929	$175,220
DAVID MACHON	MANAGING DIRECTOR OF BUSINESS	40.00	Key Emp	$170,313	$17,031	$187,344

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$7,210,359	$3,700,460	$5,920,822	$3,509,899
2023	$4,947,229	$3,200,467	$2,249,935	$1,746,762
2022	$1,631,630	$3,335,701	$609,324	$-1,704,071
2021	$6,698,252	$4,659,431	$2,244,214	$2,038,821
2020	$4,081,084	$4,087,571	$86,687	$-6,487
2019	$4,039,587	$4,171,890	$84,276	$-132,303
2018	$5,619,508	$5,585,983	$216,579	$33,525

AMERICAN FRIENDS OF CANCER RESEARCH INC